Tajarobi Farhad, Abrahmsén-Alami Susanna, Hansen Magnus, Larsson Anette
AstraZeneca R&D, Mölndal, Sweden.
Pharm Res. 2009 Jun;26(6):1496-503. doi: 10.1007/s11095-009-9861-y. Epub 2009 Mar 12.
The dissolution of HPMC matrix tablets containing different amounts of highly soluble (mannitol) or poorly soluble (dicalcium phosphate, DCP) was studied to deduce the parameters critical to release robustness.
The release of HPMC and additives was studied using a modified USP II method at two paddle stirring rates, 50 and 125 rpm, at HPMC content varying from 15% to 100%.
At HPMC contents between 30% and 35% a critical point was identified and found crucial to the release from the HPMC/mannitol tablets. Below this point the matrix rapidly disintegrated in a non robust manner. At higher HPMC contents the mannitol release became increasingly diffusion controlled with maintained matrix integrity. The release robustness was lower for HPMC/DCP than HPMC/mannitol tablets at high HPMC contents, however, lacking critical points. The critical point was interpreted as the percolation threshold for HPMC and differences explained in terms of water transport into the matrix.
The release robustness was lower for formulations with additives of low solubility having an erosion controlled release than for additives with higher solubility and a diffusion controlled release. However, for additives creating a steep osmotic pressure gradient, an HPMC content above the percolation threshold becomes vital for maintaining the release robustness.
研究含有不同量高溶解性(甘露醇)或低溶解性(磷酸氢钙,DCP)的羟丙基甲基纤维素(HPMC)骨架片的溶出情况,以推断对释放稳健性至关重要的参数。
采用改良的美国药典II法,在50和125转/分钟两种桨叶搅拌速率下,研究HPMC含量在15%至100%之间时HPMC和添加剂的释放情况。
在HPMC含量为30%至35%之间时,确定了一个临界点,发现该点对HPMC/甘露醇片的释放至关重要。低于该点时,骨架会以不稳定的方式迅速崩解。在较高的HPMC含量下,甘露醇的释放越来越受扩散控制,骨架完整性得以维持。在高HPMC含量下,HPMC/DCP片的释放稳健性低于HPMC/甘露醇片,不过不存在临界点。该临界点被解释为HPMC的渗滤阈值,并根据水向骨架内的传输来解释差异。
与具有较高溶解度和扩散控制释放的添加剂相比,含有低溶解度添加剂且为侵蚀控制释放的制剂的释放稳健性较低。然而,对于产生陡峭渗透压梯度的添加剂,高于渗滤阈值的HPMC含量对于维持释放稳健性至关重要。